Bearish flow noted in Neumora Therapeutics (NMRA) Inc with 6,162 puts trading, or 10x expected. Most active are Jan-25 5 puts and Jan-25 2.5 puts, with total volume in those strikes near 5,900 contracts. The Put/Call Ratio is 18.84, while ATM IV is up over 14 points on the day. Earnings are expected on March 6th.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMRA:
- Neumora Therapeutics Inc put volume heavy and directionally bearish
- J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital
- Neumora Therapeutics Reports Q3 2024 Financial Results
- Neumora Therapeutics reports Q3 EPS (45c), consensus (39c)
- Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan